Public case informationLast updated
Unicycive Therapeutics Securities Class Action
Unicycive Therapeutics · Unicycive Therapeutics securities · Ongoing Litigation
About this case
A securities class action has been filed on behalf of investors who purchased Unicycive Therapeutics securities between December 29, 2025, and June 29, 2026. The matter is at the filed and ongoing litigation stage, and investors may seek appointment as lead plaintiff by moving the court by November 2, 2026.
Case overview
- Defendant company
- Unicycive Therapeutics
- Product or service
- Unicycive Therapeutics securities
- Court case number
- 3:2026cv09559
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Important dates
- Lead Plaintiff Application
Participation information
Lead Plaintiff Application
Purchasers of Unicycive Therapeutics securities during the period from December 29, 2025, through June 29, 2026, may seek appointment as lead plaintiff.
Move the court no later than November 2, 2026, to seek appointment as lead plaintiff.
- Type
- Lead Plaintiff
- Status
- Upcoming
Sources
- Unicycive Therapeutics Securities Class Action
Eagle-Tribune ·
- Unicycive Therapeutics Securities Class Action
Eagle-Tribune ·
- Unicycive Therapeutics Securities Class Action
Aol ·